VascVersa

Pioneering a bold new generation of advanced therapies that decipher the code behind vision loss - helping to restore sight through retinal vascular therapy

Health and bio

Latest funding

Seed · August 8, 2022

Amount not disclosed in a source on record.

Funding history ↓

Website: vascversa.com.

Category: Health and bio.

Stage: Seed.

Last round: Aug 8, 2022 · 1,557 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredDec 19, 2018 (7 years old)

Funding rounds

August 8, 2022
Seed · amount undisclosed
Source: fundraisingfox.com
December 19, 2018
Website created

Founders and team

CO
Christina O'Neill Co-founder, CEO

source: vascversa.com
PA
Professor Alan Stitt Co-founder

source: vascversa.com
RM
Reinhold Medina Co-founder

source: vascversa.com

Companies like VascVersa

RRhyGaze$86M Series A · Jan 2025
LLucina BiotherapeuticsSeed · Aug 2026
RRestore VisionSeries A · Dec 2023
AAspen Neuroscience$115M Series B+ · Nov 2025
BBig Bold HealthSeries B+ · Jan 2025
LLifeMine Therapeutics$75M Series B+ · Aug 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vascversa (get a free API key).